# Nkarta to Participate in a September Investor Conference
Canonical URL: https://biopharmsignal.com/news/NKTX/nkarta-to-participate-in-a-september-investor-conference
Ticker: NKTX
Company: Nkarta
Source: Nkarta
Published: 2025-09-02 12:02 EST
Original Source URL: https://ir.nkartatx.com
## Summary

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: H.C.

## Article Body
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: H.C.
## Recent Company News
- 2026-05-12 20:01 EST — [Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/NKTX/nkarta-reports-first-quarter-2026-financial-results-and-corporate-highlights) — Source: Nkarta
- 2026-04-15 20:01 EST — [Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers](https://biopharmsignal.com/news/NKTX/nkarta-announces-fda-agreement-on-outpatient-dosing-of-nkx019-in-autoimmune-disease-expanding-access-to-community-rheumatology-centers) — Source: Nkarta
- 2026-04-09 11:00 EST — [Nkarta to Participate in Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/NKTX/nkarta-to-participate-in-needham-virtual-healthcare-conference) — Source: Nkarta
- 2026-03-25 20:01 EST — [Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights](https://biopharmsignal.com/news/NKTX/nkarta-reports-fourth-quarter-and-full-year-2025-financial-results-and-corporate-highlights) — Source: Nkarta
- 2026-02-27 13:00 EST — [Nkarta to Participate in March Investor Conferences](https://biopharmsignal.com/news/NKTX/nkarta-to-participate-in-march-investor-conferences) — Source: Nkarta
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)